Jiangsu Hengrui Medicine
600276.SS
#461
Rank
ยฃ35.00 B
Marketcap
ยฃ5.49
Share price
-0.54%
Change (1 day)
4.17%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ0.45 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are ยฃ0.45 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ0.47 B9.99%
2021-12-31ยฃ0.42 B-3.15%
2020-12-31ยฃ0.44 B55.12%
2019-12-31ยฃ0.28 B-3.51%
2018-12-31ยฃ0.29 B24.28%
2017-12-31ยฃ0.23 B40.32%
2016-12-31ยฃ0.16 B43.27%
2015-12-31ยฃ0.11 B22.52%
2014-12-31ยฃ96.78 M71.18%
2013-12-31ยฃ56.53 M26.61%
2012-12-31ยฃ44.65 M-0.74%
2011-12-31ยฃ44.98 M9.13%
2010-12-31ยฃ41.22 M36.48%
2009-12-31ยฃ30.2 M31.18%
2008-12-31ยฃ23.02 M-17.12%
2007-12-31ยฃ27.78 M111.25%
2006-12-31ยฃ13.15 M3.31%
2005-12-31ยฃ12.72 M-21.5%
2004-12-31ยฃ16.21 M-56.19%
2003-12-31ยฃ37.01 M24.48%
2002-12-31ยฃ29.73 M-1.17%
2001-12-31ยฃ30.08 M